The role of endobronchial ultrasound versus mediastinoscopy for non-small cell lung cancer
TLDR
EBUS-TBNA is more cost-effective than Med and it is currently recommended as the test of first choice for invasive mediastinal LN staging in lung cancer.Abstract:
This review provides an update on the current role of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) and mediastinoscopy (Med) in assessment of patients with non-small cell lung cancer (NSCLC). Invasive mediastinal lymph node (LN) staging is the major application for both of these techniques. Up until recently, Med was the gold standard for invasive mediastinal LN staging in NSCLC. However, EBUS-TBNA has shown to be equivalent, and in some studies better than Med for invasive staging of lung cancer. EBUS-TBNA offers access to N1 LNs and development of the thin convex probe EBUS (TCP-EBUS) will expand EBUS-TBNA access from the paratracheal region and central airways to more distal parabronchial regions allowing for more extensive N1 LN assessment and sampling more distal lung tumors. EBUS-TBNA is more cost-effective than Med and it is currently recommended as the test of first choice for invasive mediastinal LN staging in lung cancer. Confirmatory Med should be performed selectively in patients with high pretest probability of metastatic disease. Addition of esophageal ultrasound fine needle aspiration (EUS-FNA) may increase diagnostic yield of EBUS-TBNA mediastinal staging. Both Med and EBUS-TBNA can be used in primary lung cancer diagnosis, restaging of the mediastinum following neoadjuvant therapy and in diagnosis of lung cancer recurrence. In the future, a combination of EBUS-TBNA with or without EUS-FNA and Med is most likely going to provide the most optimal invasive assessment of the mediastinum in patients with lung cancer. The decision on test choice and sequence should be made on a case-by-case basis and factoring in local resources and expertise.read more
Citations
More filters
Journal ArticleDOI
Radiomics Approach to Prediction of Occult Mediastinal Lymph Node Metastasis of Lung Adenocarcinoma.
TL;DR: The radiomics signature of a primary tumor based on CT scans can be used for quantitative and noninvasive prediction of occult mediastinal LN metastasis of lung adenocarcinoma.
Journal ArticleDOI
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines
Francesco Passiglia,Luca Bertolaccini,M. Del Re,Francesco Facchinetti,Roberto Ferrara,Tindara Franchina,Umberto Malapelle,Jessica Menis,Antonio Passaro,Sara Pilotto,Sara Ramella,Giulio Rossi,Rocco Trisolini,Silvia Novello +13 more
TL;DR: A panel of AIOM experts in the field of thoracic malignancies discussed topics, analyzing available scientific evidences, with the final aim of providing a summary of clinical recommendations, which may guide physicians in their current practice.
Journal ArticleDOI
Is SUVmax Helpful in the Differential Diagnosis of Enlarged Mediastinal Lymph Nodes? A Pilot Study.
TL;DR: S SUVmax, a commonly used semiquantitative measurement, was not helpful for differentiation between benign and malignant lesions in patients with enlarged mediastinal lymph nodes in this study.
Journal ArticleDOI
Deep Learning for Prediction of N2 Metastasis and Survival for Clinical Stage I Non–Small Cell Lung Cancer
TL;DR: Park et al. as mentioned in this paper developed a deep learning signature for N2 metastasis prediction and prognosis stratification in clinical stage I non-small cell lung cancer (NSCLC) patients.
Journal ArticleDOI
Deep Learning for Prediction of N2 Metastasis and Survival for Clinical Stage I Non-Small Cell Lung Cancer.
Yifan Zhong,Yunlang She,Jiajun Deng,Shouyu Chen,Tingting Wang,Minglei Yang,Minjie Ma,Yongxiang Song,Haoyu Qi,Yin Wang,Jingyun Shi,Chunyan Wu,Dong Xie,Chang Chen +13 more
TL;DR: The deep learning signature could help accurately predict N2 disease and stratify prognosis in patients with clinical stage I non-small cell lung cancer as mentioned in this paper. But deep learning signatures are not suitable for the classification of lung cancer patients.
References
More filters
Journal ArticleDOI
Cancer statistics, 2016
TL;DR: Overall cancer incidence trends are stable in women, but declining by 3.1% per year in men, much of which is because of recent rapid declines in prostate cancer diagnoses, and brain cancer has surpassed leukemia as the leading cause of cancer death among children and adolescents.
Journal ArticleDOI
Methods for Staging Non-small Cell Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Gerard A. Silvestri,Anne V. Gonzalez,Michael A. Jantz,Mitchell L. Margolis,Michael K. Gould,Lynn T. Tanoue,Loren J. Harris,Frank C. Detterbeck +7 more
TL;DR: It is demonstrated that PET scanning is more accurate than CT scanning, but tissue biopsy is still required to confirm PET scan findings, and evidence suggests that more complete staging improves patient outcomes.
Journal ArticleDOI
Clinical practice. Lung cancer screening.
TL;DR: Genomic and proteomic approaches promise to complement the ability of spiral CT to detect early lung cancer in the next few years and involve a careful discussion with the individuals involved about the potential advantages, costs, and drawbacks of the approach.
Journal ArticleDOI
Real-time Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration of Mediastinal and Hilar Lymph Nodes
Kazuhiro Yasufuku,Masako Chiyo,Yasuo Sekine,Prashant N. Chhajed,Kiyoshi Shibuya,Toshihiko Iizasa,Takehiko Fujisawa +6 more
TL;DR: Real-time CP-EBUS-guided TBNA of mediastinal and hilar lymph nodes is a novel approach that is safe and has a good diagnostic yield and this new ultrasound puncture bronchoscope has an excellent potential for assisting in safe and accurate diagnostic interventional bronchoscopy.
Journal ArticleDOI
Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: A systematic review and meta-analysis
TL;DR: EBUS-TBNA was an accurate, safe and cost-effective tool in lung cancer staging and the selection of patients who had positive results of suspected lymph node metastasis in CT or PET may improve the sensitivity of EBUS- TBNA.